These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. A risk-adapted approach with a short course of ganciclovir to prevent cytomegalovirus (CMV) pneumonia in CMV-seropositive recipients of allogeneic bone marrow transplants. Verdonck LF, Dekker AW, Rozenberg-Arska M, van den Hoek MR. Clin Infect Dis; 1997 May; 24(5):901-7. PubMed ID: 9142790 [Abstract] [Full Text] [Related]
19. Clinical course of cytomegalovirus (CMV) viremia with and without ganciclovir treatment in CMV-seropositive kidney transplant recipients. Longitudinal follow-up of CMV pp65 antigenemia assay. Yang CW, Kim YO, Kim YS, Kim SY, Moon IS, Ahn HJ, Koh YB, Bang BK. Am J Nephrol; 1998 Jul; 18(5):373-8. PubMed ID: 9730559 [Abstract] [Full Text] [Related]
20. Treatment of cytomegalovirus retinitis with ganciclovir (9-[2-hydroxy-1-(hydroxymethyl) ethoxymethyl] guanine (BW B759U). Orellana J, Teich SA, Winterkorn JS, Mathur-Wagh U, Handwerger S, Schlamm H, Malamud SC, Yancovitz SR, Cederberg DM, Mildvan DS. Br J Ophthalmol; 1988 Jul; 72(7):525-9. PubMed ID: 2843219 [Abstract] [Full Text] [Related] Page: [Next] [New Search]